Johnson & Johnson (JNJ) is attempting to knock at least $100M off the $1B in cash it agreed...

|By:, SA News Editor

Johnson & Johnson (JNJ) is attempting to knock at least $100M off the $1B in cash it agreed to pay Elan (ELN) in their $1.5B deal after a judge ruled part of the deal violated Elan's partnership with Biogen Idec (BIIB). The July deal gave J&J an 18.4% stake in Elan and access to its experimental Alzheimer's drugs.